Cytori Therapeutics 8-K Shows Co. Received Written Notice From Roche Diagnostics Terminating Its Existing Supply Deal With Co. For Enzymes Used In Processing Cell Therapeutics 'due to failure by the Company to meet minimum purchase requirements'
Benzinga Newsdesk